Alefacept preserves beta cell function in some new-onset type 1 diabetes patients out to two years

Individuals with new-onset type 1 diabetes who took two courses of alefacept (Amevive®, Astellas Pharma Inc.) soon after diagnosis show preserved beta cell function after two years compared to those who received a placebo.